SCHEMBL8102874

SCHEMBL8102874

CCCC(=S)CCC(CCCCC(=O)OCCN(C)C)C(=S)CCC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 1/20 0.56
DGKA P23743 1/20 0.39
CYP3A4 P08684 1/20 0.34
TSHR P16473 1/20 0.34
ATM Q13315 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
ALDH1A1 P00352 3/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM5 P08912 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRNB2 P17787 1/20 0.33
CHRM3 P20309 1/20 0.33
CHRNA4 P43681 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA9 Q16790 1/20 0.33
PLA2G2A P14555 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7794222 0.88 DGKA (0.45) DNM1DGKACYP3A4TSHRATM
SCHEMBL7794219 0.85 CYP1A2 (0.40) DNM1DGKACYP3A4TSHRATM
SCHEMBL7792778 0.79 CTSK (0.32) CYP3A4TSHRATMTDP1LMNA
SCHEMBL7784250 0.79 LMNA (0.51) CYP3A4TSHRALDH1A1MAPTLMNA
SCHEMBL7793676 0.78 DGKA (0.45) DNM1DGKACYP3A4TSHRATM
SCHEMBL7790029 0.75 CYP1A2 (0.40) DNM1DGKACYP3A4TSHRATM
SCHEMBL8394873 0.74 DNM1 (0.96) DNM1DGKATSHRALDH1A1CHRM2
SCHEMBL1333132 0.74 DNM1 (0.81) DNM1DGKACYP3A4TSHRALDH1A1
SCHEMBL8394204 0.73 DNM1 (1.00) DNM1DGKATSHRALDH1A1THRB
SCHEMBL8397741 0.73 DNM1 (1.00) DNM1DGKATSHRALDH1A1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6117902-A 6,8-dimercaptooctanoic acid derivatives substituted at the 6-S and/or 8-S position with the (3-methylthiopropanoyl) radical and pharmaceutical compositions intended for the treatment of cancerous tumors GALDERMAN RESEARCH & DEVELOPMENT, S.N.C. SOPHIA ABTIPOLIS (FR) 2000-09-12 US disclosed